Nightingale Health Oyj B
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blo… Read more
Nightingale Health Oyj B (HEALTH) - Net Assets
Latest net assets as of June 2025: €66.17 Million EUR
Based on the latest financial reports, Nightingale Health Oyj B (HEALTH) has net assets worth €66.17 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€74.51 Million) and total liabilities (€8.35 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €66.17 Million |
| % of Total Assets | 88.8% |
| Annual Growth Rate | 49.93% |
| 5-Year Change | -46.22% |
| 10-Year Change | N/A |
| Growth Volatility | 529.17 |
Nightingale Health Oyj B - Net Assets Trend (2020–2025)
This chart illustrates how Nightingale Health Oyj B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Nightingale Health Oyj B (2020–2025)
The table below shows the annual net assets of Nightingale Health Oyj B from 2020 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | €66.17 Million | -20.17% |
| 2024-06-30 | €82.88 Million | -14.87% |
| 2023-06-30 | €97.36 Million | -12.64% |
| 2022-06-30 | €111.44 Million | -9.43% |
| 2021-06-30 | €123.04 Million | +1308.63% |
| 2020-06-30 | €8.73 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nightingale Health Oyj B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6564014000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €80.00K | 0.12% |
| Other Components | €142.58 Million | 215.49% |
| Total Equity | €66.17 Million | 100.00% |
Nightingale Health Oyj B Competitors by Market Cap
The table below lists competitors of Nightingale Health Oyj B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
YASHO INDUSTRIES ORD (BSE)
NSE:YASHO
|
$50.54 Million |
|
Durect Corporation
NASDAQ:DRRX
|
$50.56 Million |
|
Daesung Energy
KO:117580
|
$50.56 Million |
|
Village Bank and Trust Financial
NASDAQ:VBFC
|
$50.56 Million |
|
ETHZilla Corporation
NASDAQ:ETHZ
|
$50.52 Million |
|
NANOFORM FINLAND OYJ
F:4YL
|
$50.52 Million |
|
RESEARCH SOLUTIONS DL-001
F:61I
|
$50.51 Million |
|
Gabriel Holding A/S
F:1GH
|
$50.48 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nightingale Health Oyj B's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 82,880,000 to 66,166,000, a change of -16,714,000 (-20.2%).
- Net loss of 18,462,000 reduced equity.
- Share repurchases of 33,000 reduced equity.
- Other factors increased equity by 1,781,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-18.46 Million | -27.9% |
| Share Repurchases | €33.00K | -0.05% |
| Other Changes | €1.78 Million | +2.69% |
| Total Change | €- | -20.17% |
Book Value vs Market Value Analysis
This analysis compares Nightingale Health Oyj B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.30x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 10.24x to 1.30x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-06-30 | €0.14 | €1.42 | x |
| 2021-06-30 | €2.05 | €1.42 | x |
| 2022-06-30 | €1.85 | €1.42 | x |
| 2023-06-30 | €1.61 | €1.42 | x |
| 2024-06-30 | €1.37 | €1.42 | x |
| 2025-06-30 | €1.10 | €1.42 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nightingale Health Oyj B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -27.90%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -393.39%
- • Asset Turnover: 0.06x
- • Equity Multiplier: 1.13x
- Recent ROE (-27.90%) is below the historical average (-22.10%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -42.72% | -209.51% | 0.07x | 2.72x | €-4.60 Million |
| 2021 | -7.90% | -421.91% | 0.02x | 1.13x | €-22.03 Million |
| 2022 | -14.44% | -695.68% | 0.02x | 1.11x | €-27.23 Million |
| 2023 | -18.57% | -432.40% | 0.04x | 1.10x | €-27.82 Million |
| 2024 | -21.07% | -400.71% | 0.05x | 1.10x | €-25.75 Million |
| 2025 | -27.90% | -393.39% | 0.06x | 1.13x | €-25.08 Million |
Industry Comparison
This section compares Nightingale Health Oyj B's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,163,000
- Average return on equity (ROE) among peers: -248.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nightingale Health Oyj B (HEALTH) | €66.17 Million | -42.72% | 0.13x | $50.54 Million |
| Optomed PLC (OPTOMED) | $1.16 Million | -248.24% | 7.53x | $35.53 Million |